Compound Detail
CHEMBL403
SULBACTAM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL403 |
| Name | SULBACTAM |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | FKENQMMABCRJMK-RITPCOANSA-N |
| Therapeutic | ✓ Yes |
25
Targets
68
Activities
2
Assay Types
15
PK Parameters
20
Publications
3
Known Names
6
Indications
Molecular Properties
233.2
MW (Da)
-0.79
ALogP
4
HBA
1
HBD
91.8
PSA (Ų)
0.60
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1986 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Bacterial Infections Infections Urinary Tract Infections Chorioamnionitis Cleft Palate Osteomyelitis
ATC Classification
J01CG01
sulbactam
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIBACTERIALS FOR SYSTEMIC USE
Activity Summary
IC50 62 meas. best 7.12
Ki 6 meas. best 6.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-lactamase CHEMBL5439 | IC50 | 7.12 | 7.12 | 75.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.7 | 5.7258 | 200.0 | 24 |
| Beta-lactamase GES-13 CHEMBL1250341 | IC50 | 6.43 | 6.43 | 370.0 | 1 |
| Beta-lactamase TEM CHEMBL2065 | Ki | 6.1 | 6.1 | 800.0 | 1 |
| Beta-lactamase TEM CHEMBL2065 | IC50 | 6.1 | 5.6317 | 800.0 | 6 |
| Beta-lactamase CHEMBL2725 | IC50 | 6.0 | 5.1775 | 1000.0 | 4 |
| Beta-lactamase TEM CHEMBL2364670 | IC50 | 5.97 | 5.97 | 1065.9 | 1 |
| ADC-14 protein CHEMBL1667675 | IC50 | 5.95 | 5.95 | 1120.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 5.8 | 5.05 | 1600.0 | 3 |
| Escherichia coli CHEMBL354 | IC50 | 5.72 | 5.72 | 1900.0 | 1 |
| Beta-lactamase SHV-11 CHEMBL1287606 | IC50 | 5.62 | 5.62 | 2400.0 | 1 |
| Beta-lactamase bla(BEL1) CHEMBL3885670 | IC50 | 5.52 | 5.52 | 3000.0 | 1 |
| Beta-lactamase CHEMBL3885668 | IC50 | 5.52 | 5.52 | 3000.0 | 1 |
| Beta-lactamase SHV-1 CHEMBL5956 | IC50 | 5.41 | 5.41 | 3915.0 | 1 |
| Extended-spectrum beta-lactamase PER-6 CHEMBL1697666 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
| Beta-lactamase SCO-1 CHEMBL1075073 | IC50 | 5.21 | 5.21 | 6200.0 | 1 |
| Beta-lactamase CHEMBL4114 | IC50 | 5.19 | 5.19 | 6500.0 | 1 |
| Staphylococcus aureus CHEMBL352 | IC50 | 5.17 | 5.17 | 6800.0 | 1 |
| ADC-16 protein CHEMBL1667676 | IC50 | 5.11 | 5.11 | 7758.0 | 1 |
| ADC-18 protein CHEMBL1667677 | IC50 | 4.93 | 4.93 | 11650.0 | 1 |
| Class D beta-lactamase CHEMBL1255145 | IC50 | 4.92 | 4.92 | 12000.0 | 1 |
| Enterobacter cloacae CHEMBL349 | IC50 | 4.7 | 4.7 | 20000.0 | 1 |
| Beta-lactamase OXA-1 CHEMBL4951 | IC50 | 4.66 | 4.66 | 22000.0 | 1 |
| Carbapenem-hydrolizing beta-lactamase SFC-1 CHEMBL5042 | IC50 | 4.64 | 4.64 | 22700.0 | 1 |
| Beta-lactamase 1 CHEMBL5732 | IC50 | 4.6 | 4.6 | 25000.0 | 2 |
| Beta-lactamase CHEMBL2026 | IC50 | 4.59 | 4.2825 | 25495.4 | 4 |
| Beta-lactamase CHEMBL5031 | IC50 | 4.57 | 4.57 | 27000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1400.0 | ng.hr.mL-1 | - |
| AUC | 87510.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 57070.0 | ng.hr.mL-1 | Oryctolagus cuniculus |
| CL | 5.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 5.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 3.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| Cmax | 3001.2 | nM | - |
| Cmax | 383510.55 | nM | Mus musculus |
| Cmax | 322972.05 | nM | Oryctolagus cuniculus |
| Fu | 0.62 | - | Homo sapiens |
| MRT | 1.0 | hr | Homo sapiens |
| T1/2 | 1.2 | hr | Rattus norvegicus |
| T1/2 | 0.35 | hr | Mus musculus |
| T1/2 | 0.54 | hr | Oryctolagus cuniculus |
| T1/2 | 1.1 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 202 |
| 33933754 | 10.1016/j.ejmech.2021.113436 | Acinetobacter baumannii | 19 |
| 20047914 | 10.1128/aac.00367-09 | Acinetobacter baumannii | 15 |
| 20368407 | 10.1128/aac.01624-09 | Acinetobacter pittii | 15 |
| 23252553 | 10.1021/jm301490d | Unchecked | 7 |
| 20696873 | 10.1128/aac.00771-10 | Unchecked | 6 |
| - | 10.1016/S0960-894X(01)80933-1 | Beta-lactamase | 5 |
| 23252553 | 10.1021/jm301490d | Escherichia coli | 5 |
| 6273562 | 10.1021/jm00144a034 | Mus musculus | 5 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 20921316 | 10.1128/aac.00568-10 | Unchecked | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 17470648 | 10.1128/aac.00083-07 | Unchecked | 4 |
| 33933754 | 10.1016/j.ejmech.2021.113436 | Unchecked | 4 |
| 20421396 | 10.1128/aac.00197-10 | Unchecked | 4 |
| 20008772 | 10.1128/aac.00693-09 | Unchecked | 4 |
| 17043112 | 10.1128/aac.00858-06 | NON-PROTEIN TARGET | 4 |
| 20047914 | 10.1128/aac.00367-09 | Unchecked | 4 |
| 20047914 | 10.1128/aac.00367-09 | Oryctolagus cuniculus | 3 |
| 19075067 | 10.1128/aac.00085-08 | Unchecked | 3 |
Data from ChEMBL 36 via Core Engine